Bend Bioscience, has opened four new process development and manufacturing suites within its 30,000-sq.-ft. site in Bend, OR. The suites will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage forms, and includes a dedicated low humidity suite for inhalation powder encapsulation and moisture-sensitive powder handling. 

The opening completes Bend Bioscience’s 14,000-sq.-ft. process science and manufacturing facility, making a total of seven state-of-the-art manufacturing suites at the site for early-phase product development and manufacturing of enhanced dosage form products. These new suites accommodate additional cGMP processing equipment including a second pilot-scale spray dryer (300kg/hr gas flow), 100L agitated vacuum secondary dryer, and dosage form train including a 16-station Korsch X3 MFP tablet press and associated granulation, blending, and coating unit operations. 

“We are proud to showcase both our state-of-the-art facility and equipment as well as our high science and high service culture that we employ to meet our customers key formulation development and manufacturing needs,” commented Owen Murray, CEO of Bend Bioscience. He added, “This latest extension provides additional capacity and capabilities to meet growing demand from clients in the areas of particle engineering and spray drying for absorption enhancement and dry-powder inhalation.”